Potassium

Potassium

SCHEMBL830614

Cc1cccc(-c2cc(CC(C)C)c(C(=O)O)c(C(F)(F)F)n2)c1.[K]

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GFER P55789 2/20 0.41
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
HPGD P15428 1/20 0.41
KMT2A Q03164 1/20 0.41
KMO O15229 2/20 0.41
SDHB P21912 1/20 0.41
MDM2 Q00987 4/20 0.37
DHODH Q02127 1/20 0.37
MAPT P10636 1/20 0.37
DPP4 P27487 2/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
PIN1 Q13526 1/20 0.36
ENPP1 P22413 1/20 0.36
DPP8 Q6V1X1 1/20 0.36
LDHA P00338 1/20 0.36
LDHB P07195 1/20 0.36
TRPV1 Q8NER1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL839855 0.99 GFER (0.42) GFERMEN1ALDH1A1LMNAHPGD
SCHEMBL830612 0.98 GFER (0.41) GFERMEN1ALDH1A1LMNAHPGD
Potassium Ion SCHEMBL830613 0.88 SDHB (0.40) GFERMEN1ALDH1A1LMNAHPGD
SCHEMBL839634 0.86 DPP4 (0.46) GFERSDHBDHODHMAPTDPP4
SCHEMBL830007 0.86 ALDH1A1 (0.43) MEN1ALDH1A1LMNAHPGDKMT2A
SCHEMBL830771 0.85 DPP4 (0.45) GFERSDHBDHODHMAPTDPP4
SCHEMBL831905 0.83 KMO (0.45) ALDH1A1KMOMDM2DHODHDPP4
SCHEMBL839635 0.82 DHODH (0.42) DHODHMAPTLDHALDHB
SCHEMBL829506 0.81 DHODH (0.41) DHODHMAPTLDHALDHB
SCHEMBL832625 0.81 DHODH (0.36) GFERMEN1ALDH1A1LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143411-B2 Substituted 6-phenylnicotinic acids and their use BAYER ANIMAL HEALTH GMBH (DE) 2012-03-27 US disclosed
US-20100234432-A1 Substituted 6-phenylnicotinic acids and their use BAYER ANIMAL HEALTH GMBH (DE) 2010-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234432-A1 Substituted 6-phenylnicotinic acids and their use SLC5A6, FABP3, NAPRT GFER 1350/4885MEN1 3799/4885ALDH1A1 1238/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.